annual CFF:
$495.11M+$179.72M(+56.98%)Summary
- As of today (September 16, 2025), APGE annual cash flow from financing activities is $495.11 million, with the most recent change of +$179.72 million (+56.98%) on December 31, 2024.
- During the last 3 years, APGE annual CFF has risen by +$326.79 million (+194.15%).
- APGE annual CFF is now at all-time high.
Performance
APGE Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$1.18M+$558.00K(+89.71%)Summary
- As of today (September 16, 2025), APGE quarterly cash flow from financing activities is $1.18 million, with the most recent change of +$558.00 thousand (+89.71%) on June 30, 2025.
- Over the past year, APGE quarterly CFF has increased by +$1.33 million (+886.67%).
- APGE quarterly CFF is now -99.74% below its all-time high of $450.52 million, reached on March 31, 2024.
Performance
APGE quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$46.54M+$1.33M(+2.94%)Summary
- As of today (September 16, 2025), APGE TTM cash flow from financing activities is $46.54 million, with the most recent change of +$1.33 million (+2.94%) on June 30, 2025.
- Over the past year, APGE TTM CFF has dropped by -$720.91 million (-93.94%).
- APGE TTM CFF is now -93.94% below its all-time high of $767.46 million, reached on June 30, 2024.
Performance
APGE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
APGE Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +57.0% | +886.7% | -93.9% |
| 3 y3 years | +194.2% | +4638.5% | +835.7% |
| 5 y5 years | +194.2% | -76.4% | +830.8% |
APGE Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +194.2% | -99.7% | +169.7% | -93.9% | +1376.1% |
| 5 y | 5-year | at high | +194.2% | -99.7% | +169.7% | -93.9% | +1376.1% |
| alltime | all time | at high | +194.2% | -99.7% | +169.7% | -93.9% | +1376.1% |
APGE Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.18M(+89.7%) | $46.54M(+2.9%) |
| Mar 2025 | - | $622.00K(-98.6%) | $45.21M(-90.9%) |
| Dec 2024 | $495.11M(+57.0%) | $44.36M(>+9900.0%) | $495.11M(+9.9%) |
| Sep 2024 | - | $383.00K(-355.3%) | $450.54M(-41.3%) |
| Jun 2024 | - | -$150.00K(-100.0%) | $767.46M(+0.2%) |
| Mar 2024 | - | $450.52M(<-9900.0%) | $765.91M(+142.8%) |
| Dec 2023 | $315.39M | -$213.00K(-100.1%) | $315.39M(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $317.30M(<-9900.0%) | $315.60M(>+9900.0%) |
| Jun 2023 | - | -$1.69M(<-9900.0%) | $3.15M(-34.6%) |
| Mar 2023 | - | $0.00(-100.0%) | $4.82M(-50.9%) |
| Dec 2022 | $168.32M | - | - |
| Sep 2022 | - | $4.85M(<-9900.0%) | $9.82M(+97.4%) |
| Jun 2022 | - | -$26.00K(-100.5%) | $4.97M(-0.5%) |
| Mar 2022 | - | $5.00M | $5.00M |
FAQ
- What is Apogee Therapeutics, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. annual CFF year-on-year change?
- What is Apogee Therapeutics, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. quarterly CFF year-on-year change?
- What is Apogee Therapeutics, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. TTM CFF year-on-year change?
What is Apogee Therapeutics, Inc. annual cash flow from financing activities?
The current annual CFF of APGE is $495.11M
What is the all time high annual CFF for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high annual cash flow from financing activities is $495.11M
What is Apogee Therapeutics, Inc. annual CFF year-on-year change?
Over the past year, APGE annual cash flow from financing activities has changed by +$179.72M (+56.98%)
What is Apogee Therapeutics, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of APGE is $1.18M
What is the all time high quarterly CFF for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high quarterly cash flow from financing activities is $450.52M
What is Apogee Therapeutics, Inc. quarterly CFF year-on-year change?
Over the past year, APGE quarterly cash flow from financing activities has changed by +$1.33M (+886.67%)
What is Apogee Therapeutics, Inc. TTM cash flow from financing activities?
The current TTM CFF of APGE is $46.54M
What is the all time high TTM CFF for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high TTM cash flow from financing activities is $767.46M
What is Apogee Therapeutics, Inc. TTM CFF year-on-year change?
Over the past year, APGE TTM cash flow from financing activities has changed by -$720.91M (-93.94%)